From: Genomic test ends a long diagnostic odyssey in a patient with resistance to thyroid hormones
Date | Symptoms | T4 fT4 | T3 fT3 | TSH | TAB | Size | Treatment |
---|---|---|---|---|---|---|---|
6/91 | nervous, palpitation, sweating | > 200 n/a | 4.2 n/a | 1.4 | aMS+ | N | start tiamazol |
9/91 | feeling better | < 47 n/a | n/a | n/a | n/a | 2.5 N | reduced tiamazol |
3/92 | no symptoms | > 320 n/a | 4.0 n/a | 1.9 | n/a | 2.5 N | 2 months no treatm ? high ThyH carriers |
4/93 | tremor, tachycardia, weight loss | > 340 n/a | n/a | 2.1 | n/a | n/a | start tiamazol |
6/93 | no change | 279 n/a | n/a | n/a | n/a | n/a | discontinued ? high ThyH carriers |
1/94 | nervous tachycardia | 257 38 | n/a | 1.4 | n/a | n/a | start tiamazol |
5/94 | asymptomatic | 173 n/a | n/a | n/a | n/a | n/a | discontinued |
9/94 | asymptomatic | 228 46 | 2.2 n/a | 1.2 | n/a | n/a | metimazol |
11/94 | asymptomatic | 206 28 | 2.2 n/a | 1.4 | n/a | n/a | discontinued ? ThyH resistance |
9/96 | asymptomatic | 250 93 | 2.1 14 | 1.9 | n/a | n/a | no treatment |
TRH test following 7 days T3 overload – normal TSH response (basal TSH 0.23, 30′ 2.1, 60′ 1.2, 90′ 0.89) DNA sent to overseas lab for genetic testing, returned no result. | |||||||
until 8/2007 | to 184 to 79 | to 3.2 to 9.5 | to 2.7 | aHTG 37.5 aTPO 1642 | N firm | no treatment ? HT | |
until 12/2015 | lost to follow up RA on MTX, bioTx | sought international thyroid expertise, diagnosed and treated for thyrotoxicosis due to elevated fT4, fT3 and despite unsuppressed TSH | |||||
12/15 | tired, slow weight gain | n/a 31.4 | n/a 14.3 | 5.6 | n/a | firm hyperECH | ThyH replacement Hypothyroid HT |
2018 | Patient recruited in an international study of genetics of autoimmunity and underwent whole exome sequencing providing genetic confirmation of the RTH (pathogenic variant in THB, p.Arg338Trp). | ||||||
2019 |